A Safeguard System for iPSC-Derived T-Cell Therapy
Researchers showed that human immune T-cells rejuvenated using iPS cell techniques effectively reduced the size of tumors in mice, enhancing the safety of iPSC-derived T-cell therapy for eradicating target viruses by including a suicide gene in iPSC-derived T-cells that can be pharmaceutically triggered. [Press release from University of Tokyo discussing online publication in Stem Cell Reports] Press Release|Full Article|Graphical Abstract
A New Journal Wants to Publish Your Research Ideas
Do you have a great idea for a study that you want to share with the world? A new journal will gladly publish it. Research Ideas and Outcomes (RIO) will also publish papers on your methods, workflows, data, reports, and software—in short, “all outputs of the research cycle.” RIO, an open-access journal, was officially launched and will start accepting submissions in November. [ScienceInsider] Editorial
Recruit Top Talent: Reach more than 60,000 potential candidates by posting
your organization’s career opportunities on the Connexon Creative Job Board at no cost.
Have we missed an important article or publication in ESC & iPSC News? Click here to submit!